• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区帕金森病:215例患者的分析

Parkinson's disease in Taiwan: an analysis of 215 patients.

作者信息

Chia L G, Liu L H

机构信息

Neurology Section, Veterans General Hospital-Taichung, Taiwan, Republic of China.

出版信息

Neuroepidemiology. 1992;11(3):113-20. doi: 10.1159/000110920.

DOI:10.1159/000110920
PMID:1407246
Abstract

215 Chinese Parkinson's disease (PD) patients on levodopa therapy were followed up between 1982 and 1991. The ratio of males to females was 2.4 to 1. The mean durations from onset of the illness to stages I and II of Hoehn and Yahr (mild disability) were 4.0 and 6.5 years, to stage III (moderate) 7.9 years, and to stages IV and V (severe) 9.8 and 11.8 years. The mean duration of illness for living patients was 8.6 years. The mean duration of illness before death for the 46 patients who died was 8.9 years. The mean age at death was 68 years (4.4 years less than the normal life expectancy in Taiwan). The fate of this disease showed that patients with unilateral symptoms initially had a better prognosis than those with bilateral symptoms. The symptoms at onset were unilateral in 70% of the patients, of whom 91% had a spread of symptoms to the opposite side after a mean of 3.4 years. Familial PD occurred in 2.8% of our patients. The occurrence of blood ABO groups was not significantly different between the PD patients and the general population of Taiwan. Our findings differed from those in Western series by having a predominance of males, and a relatively shorter duration of unilateral symptoms before spread to the opposite side. In addition, the duration of illness and the survival time under levodopa treatment were shorter in Taiwanese and Japanese than in Western series.

摘要

1982年至1991年期间,对215名接受左旋多巴治疗的中国帕金森病(PD)患者进行了随访。男女比例为2.4比1。从发病到Hoehn和Yahr分级的I期和II期(轻度残疾)的平均病程分别为4.0年和6.5年,到III期(中度)为7.9年,到IV期和V期(重度)分别为9.8年和11.8年。存活患者的平均病程为8.6年。46名死亡患者的平均病程为8.9年。平均死亡年龄为68岁(比台湾正常预期寿命少4.4岁)。该疾病的转归显示,最初有单侧症状的患者预后比双侧症状患者更好。70%的患者起病症状为单侧,其中91%在平均3.4年后症状扩散至对侧。2.8%的患者患有家族性帕金森病。帕金森病患者与台湾普通人群的ABO血型分布无显著差异。我们的研究结果与西方系列研究不同,表现为男性占主导,单侧症状扩散至对侧之前的持续时间相对较短。此外,台湾人和日本人在左旋多巴治疗下的病程和生存时间比西方系列研究中的要短。

相似文献

1
Parkinson's disease in Taiwan: an analysis of 215 patients.台湾地区帕金森病:215例患者的分析
Neuroepidemiology. 1992;11(3):113-20. doi: 10.1159/000110920.
2
Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations.帕金森病的预后:进展至III期、IV期、V期的时间以及运动波动情况。
Mov Disord. 2006 Sep;21(9):1384-95. doi: 10.1002/mds.20993.
3
[Progress in the basic and clinical aspects of Parkinson's disease].[帕金森病基础与临床研究进展]
Rinsho Shinkeigaku. 2004 Nov;44(11):741-50.
4
[Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].[司来吉兰在日常临床应用中。帕金森病患者联合治疗的研究结果]
Fortschr Neurol Psychiatr. 2008 Oct;76(10):594-9. doi: 10.1055/s-2008-1038249. Epub 2008 Oct 2.
5
Long-term follow-up of early dopa treatment in Parkinson's disease.帕金森病早期多巴治疗的长期随访
Ann Neurol. 1986 Apr;19(4):365-72. doi: 10.1002/ana.410190410.
6
Differential progression of motor impairment in levodopa-treated Parkinson's disease.左旋多巴治疗帕金森病中运动障碍的差异进展
Mov Disord. 2000 May;15(3):479-84. doi: 10.1002/1531-8257(200005)15:3<479::AID-MDS1009>3.0.CO;2-P.
7
Clinical course of patients with idiopathic Parkinson's disease.特发性帕金森病患者的临床病程。
Mov Disord. 1996 May;11(3):236-42. doi: 10.1002/mds.870110304.
8
Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.晚期帕金森病患者左旋多巴的药代动力学-药效学建模
Clin Neuropharmacol. 2010 May;33(3):135-41. doi: 10.1097/WNF.0b013e3181d47849.
9
Parkinsonism treated with levodopa: progression and mortality.
J Neural Transm Suppl. 1983;19:253-64.
10
Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.拉各斯大学教学医院帕金森病患者的血浆同型半胱氨酸水平及其与临床特征的关系。
West Afr J Med. 2011 Sep-Oct;30(5):319-24.

引用本文的文献

1
Predictors of Loss of Functional Independence in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up and Comparison with a Control Group.帕金森病功能独立性丧失的预测因素:COPPADIS队列2年随访结果及与对照组的比较
Diagnostics (Basel). 2021 Sep 29;11(10):1801. doi: 10.3390/diagnostics11101801.
2
Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives.帕金森病非人灵长类MPTP模型中的移植:最新进展与展望
Primate Biol. 2017 Oct 11;4(2):185-213. doi: 10.5194/pb-4-185-2017. eCollection 2017.
3
ABO blood group and neurodegenerative disorders: more than a casual association.
ABO血型与神经退行性疾病:绝非偶然关联。
Blood Transfus. 2016 Mar;14(2):158-9. doi: 10.2450/2015.0169-15. Epub 2015 Nov 23.
4
A systematic review of loss of independence in Parkinson's disease.帕金森病独立性丧失的系统评价
J Neurol. 2016 Jan;263(1):1-10. doi: 10.1007/s00415-015-7847-8. Epub 2015 Jul 15.
5
Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia.俄罗斯、乌兹别克斯坦和赞比亚的家族性帕金森病研究。
Postgrad Med J. 2005 Feb;81(952):117-21. doi: 10.1136/pgmj.2004.018705.
6
Epidemiology of Parkinson's disease.帕金森病的流行病学
Neurol Clin. 1996 May;14(2):317-35. doi: 10.1016/S0733-8619(05)70259-0.